Lebenthal Global Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$542K Sell
1,393
-246
-15% -$98.2K 0.07% 153
2026
Q2
$634K Buy
+1,639
New +$608K 0.09% 152
2025
Q4
– Sell
-1,257
Closed -$406K – 194
2025
Q3
$406K Sell
1,257
-288
-19% -$89.6K 0.07% 158
2025
Q2
$601K Buy
1,545
+238
+18% +$95.7K 0.11% 124
2025
Q1
$568K Buy
+1,307
New +$525K 0.11% 122
2024
Q4
– Sell
-525
Closed -$273K – 199
2024
Q3
$273K Buy
525
+22
+4% +$11.8K 0.06% 165
2024
Q2
$273K Buy
503
+3
+0.6% +$1.59K 0.06% 161
2024
Q1
$259K Buy
500
+43
+9% +$21.4K 0.06% 171
2023
Q4
$216K Buy
+457
New +$211K 0.05% 181

Other funds holding ELV

Lebenthal Global Advisors's ELV Position: Q3 2026 in Review

Lebenthal Global Advisors reduced its Elevance Health (ELV) stake by 15% in Q3 2026, selling an estimated $98.2K and leaving 1,393 shares worth $542K. The position accounts for 0.07% of the portfolio, ranked #153.

Lebenthal Global Advisors first reported a position in ELV in Q4 2023 and has held it in 9 quarters since. The position peaked at $634K in Q2 2026. 1,621 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Lebenthal Global Advisors held 1,393 shares of Elevance Health worth $542K as of Q3 2026.
  • Lebenthal Global Advisors sold 246 Elevance Health shares in Q3 2026, an estimated $98.2K.
  • Elevance Health made up 0.07% of Lebenthal Global Advisors's portfolio in Q3 2026, its #153 holding.
  • Lebenthal Global Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 9 quarters since.
  • Lebenthal Global Advisors's Elevance Health position peaked at $634K in Q2 2026.
  • 1,621 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Lebenthal Global Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.